MedTrace Logo

Development of Self-regulation by Dialectial Behavioural Therapy in Adults With Autism

NCT05502484 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-08-16

No results posted yet for this study

Summary

Individuals with autism spectrum disorder (ASD) are at risk to develop more pervasive emotion-dysregulation. In this study experiences of adults with ASD and severe emotion dysregulation with Integrative Dialectical Behaviour Therapy (DBT) and the mechanisms and processes that hinder and advance the pathway to recovery will be studied, in order to make the treatment more tailored and effective for this target group.

Conditions

Interventions

BEHAVIORAL

Integrative Dialectical Behavioural Therapy (DBT)

8 weeks outpatient pre-treatment DBT followed by integrative, inpatient DBT of 40 weeks, using standard DBT, augmented with an experience-oriented, body-oriented skills training based on DBT-principles by trained DBT-therapists, and a follow-up phase of 12 weeks outpatient aftercare (maximal 8 sessions individual DBT and 4 booster sessions) and 12 weeks no DBT. The inpatient treatment takes place in a living environment that is based on the principles of DBT and takes into account several aspects of autism.

Sponsors & Collaborators

  • Dimence mental health institute

    collaborator UNKNOWN

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Ella Lobregt-van Buuren, MSc · Dimence mental health institute

  • Nanda Lambregts-Rommelse, PhD · Radboud University Medical Center

  • Wouter Staal, PhD · Radboud University Medical Center

  • Lisette Verhoeven, PhD · Dr. Leo Kannerhuis

  • Peter Goossens, PhD · Dimence mental health institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Netherlands

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05502484 on ClinicalTrials.gov